Febuxostat Linked to Higher Liver Toxicity Than Benzbromarone in Gout Patients: Study Dr. Shravani Dali20 April 2025 9:00 PM ISTResearchers have found in a recent study that febuxostat carries a significantly greater risk of liver function disturbances compared to benzbromarone...
Ibuprofen and naproxen reduce cardiovascular risk in gout patients, reveals study Jacinthlyn Sylvia25 April 2024 8:00 PM ISTA recent research found that the use of non-steroidal anti-inflammatory drugs (NSAIDs) might reduce the risk of cardiovascular events in the patients...
Tigulixostat significantly reduces serum urate concentration in gout patients Jacinthlyn Sylvia23 Jan 2023 10:00 AM ISTA study by Robert Terkeltaub and peers found that Tigulixostat (nonpurine xanthine oxidase inhibitor) reduces serum urate (sUA) levels in gout...
Flare up of gout linked to increased risk MI and stroke: JAMA Dr. Kamal Kant Kohli6 Aug 2022 9:15 AM ISTExperts at the University of Nottingham, in collaboration with experts at Keele University, have found that the risk of heart attacks and strokes...
Should clinicians reconsider standard therapy for gout? Isra Zaman9 July 2022 9:30 AM ISTGout occurs when urate crystals accumulate in the joints, and xanthine oxidase inhibitors such as febuxostat are a mainstay of therapy to help...
Worn shoes cause structural changes in foot loading in gout patients: Study Dr Satabdi Saha10 Jun 2021 6:30 PM IST A recent study found signs of wear on the upper, midsole and outsole in the worn footwear after six-months. These changes to the structural...
